Howard W. Robin, President & CEO at NEKTAR THERAPEUTICS (NKTR), sold 4,414 shares at $54.28 ($240K) on 2025-11-25, disclosed to the SEC on 2025-11-25.
Seasonal sale ($240k) by President & CEO — this insider has traded NKTR in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.28 | 2,207 | $120K | 50.0% |
| 2 | $54.28 | 2,207 | $120K | 50.0% |
| Total | $54.28 avg | 4,414 | $240K | 100% |
| Filing → |
| NKTR | SELL | 2026-05-21 | $29K | — | Filing → |
| NKTR | SELL | 2026-02-20 | $31K | — | Filing → |
| NKTR | SELL | 2025-09-11 | $528K | — | Filing → |